Nine Masts Capital’s Ocugen OCGN Stock Holding History

Nine Masts Capital’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,938	Closed	-$39.7K	–	259
2026 Q1	$39.7K	Buy	+21,938	New	+$37.9K	0.01%	181

Other funds holding OCGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nine Masts Capital's OCGN Position: Q2 2026 in Review

Nine Masts Capital sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 21,938 shares — an estimated $39.7K sold.

Nine Masts Capital first reported a position in OCGN in Q1 2026 and held it in 1 quarter. The position peaked at $39.7K in Q1 2026. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

Nine Masts Capital reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
Nine Masts Capital sold 21,938 Ocugen shares in Q2 2026, an estimated $39.7K.
Nine Masts Capital first reported a position in Ocugen in Q1 2026 and held it in 1 quarter.
Nine Masts Capital's Ocugen position peaked at $39.7K in Q1 2026.
147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.